Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants
    Published on 2026-04-28
    3 months ago
  • Lasting effects of early-life oxytocin treatment on LTP and episodic memory in a mouse model of Fragile X syndrome
    Published on 2026-04-28
    3 months ago
  • A frontotemporal dementia–like phenotype in schizophrenia: links to striatal dopamine and iron accumulation
    Published on 2026-04-25
    3 months ago
  • A phase 2 randomized controlled trial of luvadaxistat in treatment of adults with cognitive impairment associated with schizophrenia: results from the ERUDITE study
    Published on 2026-04-24
    3 months ago
  • Adolescent obesity induces sex-specific alterations of action control
    Published on 2026-04-23
    3 months ago
  • Neural response to reward uncertainty in adolescents with mood and anxiety symptoms
    Published on 2026-04-23
    3 months ago
  • Target engagement in a head-to-head clinical trial of dysphoric versus anxiosomatic transcranial magnetic stimulation targets
    Published on 2026-04-22
    3 months ago
« Previous 1 … 11 12 13 14 15 … 143 Next »
Journal of Psychopharmacology
  • Clozapine treatment in adolescents with schizophrenia and autism spectrum disorder: Comparative clinical profiles and treatment outcomes from a retrospective study
    Published on 2026-02-16
    5 months ago
  • Neurobiology and neuropharmacology of zebrafish social behavior
    Published on 2026-02-16
    5 months ago
  • Time to lithium: A case register study of lithium initiation in bipolar disorder
    Published on 2026-02-14
    5 months ago
  • Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compounds
    Published on 2026-02-06
    6 months ago
  • Risk of major congenital malformations and heart defects in pregnancies exposed to first-trimester drugs for depression and co-medications
    Published on 2026-02-02
    6 months ago
  • Negative affect interacts with perceptual affective biases
    Published on 2026-02-02
    6 months ago
  • Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration
    Published on 2026-01-31
    6 months ago
« Previous 1 … 11 12 13 14 15 … 150 Next »
European Neuropsychopharmacology
  • Child and maternal hair oxytocin: A novel biomarker of dyadic emotional availability
    Published on 2026-01-17
    6 months ago
  • Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols
    Published on 2026-01-17
    6 months ago
  • Response to the letter regarding “Default mode network integrity across neuropsychiatric disorders and its relation to social dysfunction: A normative modelling approach”
    Published on 2026-01-15
    6 months ago
  • Biomarker innovations in precision psychiatry diagnostics and treatment strategies
    Published on 2026-01-15
    6 months ago
  • Risk of schizophrenia-spectrum disorders among individuals with eating disorders: a nation-wide cohort study
    Published on 2026-01-08
    7 months ago
  • Epigenetic Clocks: An emerging role for Biomarkers of Aging in Psychiatry
    Published on 2026-01-08
    7 months ago
  • Publisher’s Note
    Published on 2026-01-03
    7 months ago
« Previous 1 … 11 12 13 14 15 … 168 Next »

   Pharma Pub